Latest Postherpetic neuralgia Stories
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/qx6h7s/investigation) has announced the addition of the
Pivotal pharmacokinetic bridging clinical study anticipated to begin in May MALVERN, Pa., March 24, 2014 /PRNewswire/ -- Scilex Pharmaceuticals, Inc., a company engaged in the development
Funds to be used for the clinical development of the Company's first product Ztilido(TM) (lidocaine patch 1.8%) MALVERN, Pa., March 21, 2014 /PRNewswire/ -- Scilex Pharmaceuticals,
NEWARK, Calif., March 10, 2014 /PRNewswire/ -- Depomed, Inc.
NEWARK, Calif., March 05, 2014 /PRNewswire/ -- Depomed, Inc.
NEWARK, Calif., Feb. 20, 2014 /PRNewswire/ -- Depomed, Inc.
MELBOURNE, Australia, February 5, 2014 /PRNewswire/ -- - Phase 2 trial met its primary endpoint, reduced pain in postherpetic neuralgia (PHN) versus
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
- An imitative word; an onomatopoetic word.